Citigroup’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,100
Closed -$4.72M 6130
2025
Q4
$4.72M Buy
+10,100
New +$4.69M ﹤0.01% 2054
2025
Q2
Sell
-130,000
Closed -$44.9M 5754
2025
Q1
$44.9M Buy
130,000
+122,000
+1,525% +$39.2M 0.02% 586
2024
Q4
$2.4M Hold
8,000
﹤0.01% 2662
2024
Q3
$3.25M Sell
8,000
-38,900
-83% -$14.2M ﹤0.01% 2223
2024
Q2
$15.1M Buy
46,900
+12,700
+37% +$4.13M 0.01% 1037
2024
Q1
$11.4M Sell
34,200
-42,600
-55% -$13M 0.01% 1177
2023
Q4
$20.8M Buy
76,800
+43,800
+133% +$10.8M 0.01% 839
2023
Q3
$8.12M Buy
33,000
+11,000
+50% +$3.01M 0.01% 1203
2023
Q2
$6.68M Buy
22,000
+4,000
+22% +$1.11M ﹤0.01% 1328
2023
Q1
$4.75M Sell
18,000
-152,800
-89% -$38.8M ﹤0.01% 1535
2022
Q4
$41M Buy
170,800
+46,000
+37% +$10.3M 0.03% 469
2022
Q3
$22.9M Buy
+124,800
New +$24.9M 0.02% 721
2021
Q2
Sell
-108,000
Closed -$20.3M 6239
2021
Q1
$20.3M Buy
108,000
+15,400
+17% +$2.72M 0.01% 942
2020
Q4
$15.2M Sell
92,600
-25,300
-21% -$3.7M 0.01% 1231
2020
Q3
$14.7M Buy
117,900
+33,800
+40% +$4.18M 0.01% 1095
2020
Q2
$8.16M Sell
84,100
-19,300
-19% -$2.01M 0.01% 1464
2020
Q1
$9.29M Sell
103,400
-7,300
-7% -$945K 0.01% 1212
2019
Q4
$16.4M Buy
110,700
+28,400
+35% +$3.81M 0.01% 1103
2019
Q3
$9.91M Buy
82,300
+36,800
+81% +$4.76M 0.01% 1404
2019
Q2
$6.15M Buy
45,500
+15,100
+50% +$1.91M 0.01% 1800
2019
Q1
$3.96M Sell
30,400
-41,000
-57% -$5.51M ﹤0.01% 1996
2018
Q4
$8.89M Sell
71,400
-2,100
-3% -$282K 0.01% 1347
2018
Q3
$10.2M Sell
73,500
-16,700
-19% -$2.08M 0.01% 1274
2018
Q2
$9.26M Buy
90,200
+6,800
+8% +$688K 0.01% 1337
2018
Q1
$8.09M Sell
83,400
-49,300
-37% -$4.78M 0.01% 1398
2017
Q4
$11.7M Buy
132,700
+45,700
+53% +$3.67M 0.01% 1180
2017
Q3
$6.92M Sell
87,000
-9,200
-10% -$740K 0.01% 1492
2017
Q2
$8.39M Sell
96,200
-246,700
-72% -$20.9M 0.01% 1278
2017
Q1
$30.5M Buy
342,900
+192,800
+128% +$16.1M 0.03% 562
2016
Q4
$11.1M Buy
150,100
+101,300
+208% +$7.59M 0.01% 1115
2016
Q3
$3.69M Sell
48,800
-19,700
-29% -$1.51M ﹤0.01% 1952
2016
Q2
$5.28M Buy
68,500
+4,700
+7% +$371K 0.01% 1534
2016
Q1
$4.98M Buy
63,800
+32,300
+103% +$2.26M 0.01% 1563
2015
Q4
$2.13M Sell
31,500
-26,700
-46% -$1.86M ﹤0.01% 2435
2015
Q3
$4.5M Sell
58,200
-125,300
-68% -$11.1M ﹤0.01% 1748
2015
Q2
$16.6M Buy
183,500
+123,300
+205% +$9.88M 0.01% 892
2015
Q1
$4.53M Sell
60,200
-470,800
-89% -$33.8M ﹤0.01% 1816
2014
Q4
$39M Buy
531,000
+77,200
+17% +$5.43M 0.03% 498
2014
Q3
$32M Buy
453,800
+141,500
+45% +$9.35M 0.03% 569
2014
Q2
$17.6M Buy
312,300
+260,000
+497% +$13.7M 0.02% 876
2014
Q1
$2.75M Sell
52,300
-68,800
-57% -$3.42M ﹤0.01% 2148
2013
Q4
$5.78M Sell
121,100
-54,900
-31% -$2.54M 0.01% 1674
2013
Q3
$7.52M Buy
176,000
+59,600
+51% +$2.33M 0.01% 1415
2013
Q2
$4.2M Buy
+116,400
New +$4.5M ﹤0.01% 1778

Other funds holding HCA

Citigroup's HCA Position: Q1 2026 in Review

Citigroup reduced its HCA Healthcare (HCA) stake by 0.99% in Q1 2026, selling an estimated $1.18M and leaving 233,479 shares worth $110M. The position accounts for 0.05% of the portfolio, ranked #375.

Citigroup first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Citigroup held 233,479 shares of HCA Healthcare worth $110M as of Q1 2026.
  • Citigroup sold 2,343 HCA Healthcare shares in Q1 2026, an estimated $1.18M.
  • HCA Healthcare made up 0.05% of Citigroup's portfolio in Q1 2026, its #375 holding.
  • Citigroup first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.